Vitalhub Corp. (TSE:VHI) Given Consensus Recommendation of “Buy” by Brokerages

Vitalhub Corp. (TSE:VHI) has been given an average rating of “Buy” by the seven ratings firms that are currently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is C$13.14.

Separately, National Bank Financial reduced their price target on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 27th.

Vitalhub Stock Up 0.9%

VHI stock opened at C$6.58 on Monday. The business has a fifty day moving average of C$7.16 and a two-hundred day moving average of C$7.71. The stock has a market cap of C$416.25 million, a price-to-earnings ratio of 54.83, a price-to-earnings-growth ratio of 1.18 and a beta of 0.91. Vitalhub has a 52-week low of C$6.46 and a 52-week high of C$14.64.

Vitalhub (TSE:VHI) last released its quarterly earnings results on Thursday, May 7th. The company reported C$0.04 earnings per share for the quarter. Vitalhub had a return on equity of 2.98% and a net margin of 6.13%.The business had revenue of C$31.91 million during the quarter. As a group, sell-side analysts anticipate that Vitalhub will post 0.2296467 EPS for the current year.

Vitalhub Company Profile

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.